BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grimsey NL, Savinainen JR, Attili B, Ahamed M. Regulating membrane lipid levels at the synapse by small-molecule inhibitors of monoacylglycerol lipase: new developments in therapeutic and PET imaging applications. Drug Discov Today 2020;25:330-43. [PMID: 31622747 DOI: 10.1016/j.drudis.2019.10.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Cheng R, Fujinaga M, Yang J, Rong J, Haider A, Ogasawara D, Van RS, Shao T, Chen Z, Zhang X, Calderon Leon ER, Zhang Y, Mori W, Kumata K, Yamasaki T, Xie L, Sun S, Wang L, Ran C, Shao Y, Cravatt B, Josephson L, Zhang MR, Liang SH. A novel monoacylglycerol lipase-targeted 18F-labeled probe for positron emission tomography imaging of brown adipose tissue in the energy network. Acta Pharmacol Sin 2022. [PMID: 35513432 DOI: 10.1038/s41401-022-00912-8] [Reference Citation Analysis]
2 Hasan N, Imran M, Sheikh A, Saad S, Chaudhary G, Jain GK, Kesharwani P, Ahmad FJ. Cannabis as a potential compound against various malignancies, legal aspects, advancement by exploiting nanotechnology and clinical trials. J Drug Target 2022;:1-17. [PMID: 35321629 DOI: 10.1080/1061186X.2022.2056188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Arakawa R, Takano A, Nag S, Jia Z, Amini N, Maresca KP, Zhang L, Keliher EJ, Butler CR, Piro JR, Samad TA, Smith D, Nason D, O'Neil S, Trapa P, Fonseca KR, Litchfield J, McCarthy T, Carson RE, Halldin C. Target occupancy study and whole-body dosimetry with a MAGL PET ligand [11C]PF-06809247 in non-human primates. EJNMMI Res 2022;12:13. [PMID: 35244788 DOI: 10.1186/s13550-022-00882-2] [Reference Citation Analysis]
4 Sabnis RW. Heterocyclic Compounds as Monoacylglycerol Lipase (MAGL) Inhibitors. ACS Med Chem Lett 2021;12:536-7. [PMID: 33859792 DOI: 10.1021/acsmedchemlett.1c00149] [Reference Citation Analysis]
5 Sabnis RW. Novel Oxazine Monoacylglycerol Lipase (MAGL) Inhibitors. ACS Med Chem Lett 2021;12:312-3. [PMID: 33738048 DOI: 10.1021/acsmedchemlett.1c00055] [Reference Citation Analysis]
6 Duggan PJ. The Chemistry of Cannabis and Cannabinoids. Aust J Chem 2021;74:369. [DOI: 10.1071/ch21006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
7 Bononi G, Poli G, Rizzolio F, Tuccinardi T, Macchia M, Minutolo F, Granchi C. An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present). Expert Opin Ther Pat 2021;31:153-68. [PMID: 33085920 DOI: 10.1080/13543776.2021.1841166] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
8 de Los Ríos-Pérez L, Brunner RM, Hadlich F, Rebl A, Kühn C, Wittenburg D, Goldammer T, Verleih M. Comparative Analysis of the Transcriptome and Distribution of Putative SNPs in Two Rainbow Trout (Oncorhynchus mykiss) Breeding Strains by Using Next-Generation Sequencing. Genes (Basel) 2020;11:E841. [PMID: 32722051 DOI: 10.3390/genes11080841] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Varlow C, Boileau I, Wey HY, Liang SH, Vasdev N. Classics in Neuroimaging: Imaging the Endocannabinoid Pathway with PET. ACS Chem Neurosci 2020;11:1855-62. [PMID: 32559067 DOI: 10.1021/acschemneuro.0c00305] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Onaivi ES, Singh Chauhan BP, Sharma V. Challenges of cannabinoid delivery: how can nanomedicine help? Nanomedicine (Lond) 2020;15:2023-8. [PMID: 32589080 DOI: 10.2217/nnm-2020-0221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]